Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 43, Issue 1 (January 2018) In this issue Editorial Review Articles Hot Topics Also new AOP   Facebook Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top Cannabis and Cannabinoids: From Synapse to Society Margaret Haney and Matthew N Hill Neuropsychopharmacology 2018 43: 1-3; 10.1038/npp.2017.255 Full Text Review Articles Top CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity OPEN Arnau Busquets-Garcia, Jaideep Bains and Giovanni Marsicano Neuropsychopharmacology 2018 43: 4-20; advance online publication, September 1, 2017; 10.1038/npp.2017.206 Abstract | Full Text The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development Heidi C Meyer, Francis S Lee and Dylan G Gee Neuropsychopharmacology 2018 43: 21-33; advance online publication, July 7, 2017; 10.1038/npp.2017.143 Abstract | Full Text Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective Ziva D Cooper and Rebecca M Craft Neuropsychopharmacology 2018 43: 34-51; advance online publication, July 17, 2017; 10.1038/npp.2017.140 Abstract | Full Text The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain Giulia Donvito, Sara R Nass, Jenny L Wilkerson, Zachary A Curry, Lesley D Schurman, Steven G Kinsey and Aron H Lichtman Neuropsychopharmacology 2018 43: 52-79; advance online publication, August 31, 2017; 10.1038/npp.2017.204 Abstract | Full Text Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder Matthew N Hill, Patrizia Campolongo, Rachel Yehuda and Sachin Patel Neuropsychopharmacology 2018 43: 80-102; advance online publication, July 26, 2017; 10.1038/npp.2017.162 Abstract | Full Text Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling J M Wenzel and J F Cheer Neuropsychopharmacology 2018 43: 103-115; advance online publication, June 27, 2017; 10.1038/npp.2017.126 Abstract | Full Text Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure Leigh V Panlilio and Zuzana Justinova Neuropsychopharmacology 2018 43: 116-141; advance online publication, August 28, 2017; 10.1038/npp.2017.193 Abstract | Full Text Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol Douglas L Boggs, Jacques D Nguyen, Daralyn Morgenson, Michael A Taffe and Mohini Ranganathan Neuropsychopharmacology 2018 43: 142-154; advance online publication, September 6, 2017; 10.1038/npp.2017.209 Abstract | Full Text Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Cecilia J Hillard Neuropsychopharmacology 2018 43: 155-172; advance online publication, June 27, 2017; 10.1038/npp.2017.130 Abstract | Full Text The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal Christina A Brezing and Frances R Levin Neuropsychopharmacology 2018 43: 173-194; advance online publication, September 6, 2017; 10.1038/npp.2017.212 Abstract | Full Text US Epidemiology of Cannabis Use and Associated Problems OPEN Deborah S Hasin Neuropsychopharmacology 2018 43: 195-212; advance online publication, August 30, 2017; 10.1038/npp.2017.198 Abstract | Full Text Hot Topics Top Toward a Translationally Relevant Preclinical Model of Cannabis Use Ryan J McLaughlin Neuropsychopharmacology 2018 43: 213; 10.1038/npp.2017.191 Full Text Setting the Legal Age for Access to Cannabis in Canada: Bridging Neuroscience, Policy, and Prevention Rebecca J Haines-Saah and Emily K Jenkins Neuropsychopharmacology 2018 43: 213-214; 10.1038/npp.2017.234 Full Text Medical Cannabis Research: Issues and Priorities Mark A Ware Neuropsychopharmacology 2018 43: 214-215; 10.1038/npp.2017.222 Full Text Selective Adenylyl Cyclase Type 1 Inhibitors as Potential Opioid Alternatives For Chronic Pain Val J Watts Neuropsychopharmacology 2018 43: 215-216; 10.1038/npp.2017.190 Full Text Novel Synthetic Opioids and Overdose Deaths: Tip of the Iceberg? Michael H Baumann and Gavril W Pasternak Neuropsychopharmacology 2018 43: 216-217; 10.1038/npp.2017.211 Full Text Opioidergic regulation of pain and pleasure in human social relationships Lauri Nummenmaa and Tomi Karjalainen Neuropsychopharmacology 2018 43: 217-218; 10.1038/npp.2017.200 Full Text Modulating Amygdala–Hippocampal Network Communication: A Potential Therapy for Neuropsychiatric Disorders Jie Zheng and Jack J Lin Neuropsychopharmacology 2018 43: 218-219; 10.1038/npp.2017.201 Full Text Modeling Non-Syndromic Autism with Human-Induced Pluripotent Stem Cells Luke AD Bury and Anthony Wynshaw-Boris Neuropsychopharmacology 2018 43: 219-220; 10.1038/npp.2017.195 Full Text Innovative Therapeutic Intervention For Opioid Use Disorder F Gerard Moeller and Kathryn A Cunningham Neuropsychopharmacology 2018 43: 220-221; 10.1038/npp.2017.192 Full Text The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects Ege T Kavalali and Lisa M Monteggia Neuropsychopharmacology 2018 43: 221-222; 10.1038/npp.2017.210 Full Text Cognitive Signaling in Cerebellar Granule Cells Mark J Wagner Neuropsychopharmacology 2018 43: 222-223; 10.1038/npp.2017.186 Full Text The Promise of Genome Editing for Modeling Psychiatric Disorders Stephanie PB Caligiuri and Paul J Kenny Neuropsychopharmacology 2018 43: 223-224; 10.1038/npp.2017.197 Full Text Aggression Addiction and Relapse: A New Frontier in Psychiatry Sam A Golden and Yavin Shaham Neuropsychopharmacology 2018 43: 224-225; 10.1038/npp.2017.173 Full Text Computational Approaches to Behavior Analysis in Psychiatry Cheryl M Corcoran and Guillermo A Cecchi Neuropsychopharmacology 2018 43: 225-226; 10.1038/npp.2017.188 Full Text Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder Anantha Shekhar and Ganesh A Thakur Neuropsychopharmacology 2018 43: 226-227; 10.1038/npp.2017.230 Full Text Integrating ‘Omics’ Approaches to Prioritize New Pathogenetic Mechanisms for Mental Disorders OPEN Annamaria Cattaneo and Carmine M Pariante Neuropsychopharmacology 2018 43: 227-228; 10.1038/npp.2017.221 Full Text A Translational Model to Assess Sign-Tracking and Goal-Tracking Behavior in Children Michelle A Joyner, Ashley N Gearhardt and Shelly B Flagel Neuropsychopharmacology 2018 43: 228-229; 10.1038/npp.2017.196 Full Text The Role of Mitochondrial Glutamate Metabolism in Cognitive Development and Disease Ozan Baytaş and Eric M Morrow Neuropsychopharmacology 2018 43: 229-230; 10.1038/npp.2017.202 Full Text Cross-Species Neurophysiological Biomarkers of Attentional Dysfunction in Schizophrenia: Bridging the Translational Gap Jared W Young and Gregory A Light Neuropsychopharmacology 2018 43: 230-231; 10.1038/npp.2017.218 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.